University of Tasmania
Browse

File(s) not publicly available

Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy

journal contribution
posted on 2023-05-18, 21:55 authored by Gregory PetersonGregory Peterson, Boyle, RR, Francis, HW, Oliver, NW, Paterson, J, von Witt, RJ, George TaylorGeorge Taylor
This study examined dosage prescribing patterns and steady-state oxipurinol plasma concentrations in 66 patients receiving chronic allopurinol therapy. Most patients (65%) were taking 300 mg allopurinol daily, although renal impairment was common. Using published guidelines, it was estimated that 35% of patients were receiving excessive dosages of allopurinol. Consequently, the plasma oxipurinol concentrations were often very high (mean (SD) was 156 (109) mumol.l-1). Accumulation of oxipurinol was inversely related to renal function. Plasma concentrations of oxipurinol and urate were not significantly related. However, most patients with oxipurinol concentrations of up to 100 mumol.l-1 had urate concentrations within the normal reference range.

History

Publication title

European journal of clinical pharmacology

Volume

39

Issue

4

Pagination

419-21

ISSN

0031-6970

Department/School

College Office - College of Health and Medicine

Publisher

Springer-Verlag

Place of publication

United States

Repository Status

  • Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC